Physician
Roth, Olitsa
Roth, Olitsa was paid $7.17M by Medicaid between Jan 2018 and Sep 2024, across 63 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 40% of everything it billed.
33Billing provider infoROTH, OLITSA
BROOKLYN, NY 11219
BROOKLYN, NY 11219
33aNPI1669402061assigned 07/03/2006
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$7.17M
24GClaims252,643
24DCodes billed63
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in New York
Rank by total paid#5 of 161
Median peer was paid$100K
This provider vs. median72×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 43,614 | $1.45M | |
| 2019 | 61,802 | $1.41M | |
| 2020 | 76,711 | $2.00M | |
| 2021 | 35,563 | $1.14M | |
| 2022 | 18,961 | $637K | |
| 2023 | 15,795 | $535K | |
| 2024incomplete | 197 | $7K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 40% | 36,565 | 30,285 | $2.87M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10.0% | 16,241 | 14,915 | $716K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.1% | 5,561 | 5,556 | $585K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.7% | 4,247 | 4,126 | $480K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.5% | 4,563 | 4,558 | $469K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.7% | 4,323 | 4,294 | $408K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.6% | 16,045 | 15,701 | $399K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.2% | 2,243 | 2,241 | $227K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.2% | 26,475 | 23,486 | $160K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 6,554 | 5,404 | $131K |
| 87070 | 1.8% | 23,071 | 20,606 | $126K | |
| 87184 | 1.4% | 23,069 | 20,605 | $102K |
51 more codes
| 92551 | 1.2% | 8,442 | $87K | |
| 99050 | 1.2% | 8,695 | $83K | |
| 69210 | <1% | 907 | $45K | |
| 99460 | <1% | 543 | $34K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 617 | $33K |
| 96127 | <1% | 4,428 | $26K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,565 | $23K |
| 83655 | <1% | 2,334 | $22K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,249 | $22K |
| 85018 | <1% | 13,260 | $21K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 146 | $15K |
| 99188 | <1% | 1,127 | $15K | |
| 99173 | <1% | 6,364 | $15K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,751 | $13K |
| 99381 | <1% | 106 | $10K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 446 | $5K |
| 92557 | <1% | 105 | $5K | |
| 17250 | <1% | 68 | $4K | |
| D1206 | Topical application of fluoride varnish | <1% | 140 | $4K |
| 10060 | <1% | 34 | $4K | |
| 96160 | <1% | 1,555 | $3K | |
| 81002 | <1% | 1,091 | $2K | |
| 96161 | <1% | 918 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 843 | $1K |
| 51701 | <1% | 28 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 927 | $562.59 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 21 | $410.35 |
| 87807 | <1% | 68 | $358.07 | |
| 99462 | <1% | 14 | $202.56 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 16 | $160.00 |
| 94760 | <1% | 197 | $135.40 | |
| 90686 | <1% | 505 | $98.99 | |
| 90715 | <1% | 113 | $77.45 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 166 | $31.09 |
| 36416 | <1% | 13,761 | $21.08 | |
| 90688 | <1% | 705 | $18.84 | |
| 99000 | <1% | 1,031 | $0.14 | |
| 90670 | 0% | 975 | $0.00 | |
| 90700 | 0% | 558 | $0.00 | |
| 90633 | 0% | 394 | $0.00 | |
| 90713 | 0% | 301 | $0.00 | |
| 90707 | 0% | 407 | $0.00 | |
| 90734 | 0% | 183 | $0.00 | |
| 87400 | 0% | 150 | $0.00 | |
| 90744 | 0% | 863 | $0.00 | |
| 90698 | 0% | 751 | $0.00 | |
| 90647 | 0% | 228 | $0.00 | |
| 90716 | 0% | 465 | $0.00 | |
| 90619 | 0% | 49 | $0.00 | |
| 97802 | 0% | 59 | $0.00 | |
| 90696 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.